Jasper van Genugten

I joined the Van Lohuizen lab in 2018 as a PhD student. In my project, I use CRISPR-Cas9 screens to identify novel genetic vulnerabilities in mesothelioma, with the aim of finding novel drug targets to treat this aggressive disease.